• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUMO化修饰及其在癌症中的作用

Sumoylation and Its Contribution to Cancer.

作者信息

Lee Jason S, Choi Hee June, Baek Sung Hee

机构信息

Department of Biological Sciences, Seoul National University, Seoul, 151-742, South Korea.

出版信息

Adv Exp Med Biol. 2017;963:283-298. doi: 10.1007/978-3-319-50044-7_17.

DOI:10.1007/978-3-319-50044-7_17
PMID:28197919
Abstract

Post-translational modifications play an important role in regulating protein activity by altering their functions. Sumoylation is a highly dynamic process which is tightly regulated by a fine balance between conjugating and deconjugating enzyme activities. It affects intracellular localization and their interaction with their binding partners, thereby changing gene expression. Consequently, these changes in turn affect signaling mechanisms that regulate many cellular functions, such as cell growth, proliferation, apoptosis , DNA repair , and cell survival. It is becoming apparent that deregulation in the SUMO pathway contributes to oncogenic transformation by affecting sumoylation/desumoylation of many oncoproteins and tumor suppressors. Loss of balance between sumoylation and desumoylation has been reported in a number of studies in a variety of disease types including cancer. This chapter summarizes the mechanisms and functions of the deregulated SUMO pathway affecting oncogenes and tumor suppressor genes.

摘要

翻译后修饰通过改变蛋白质功能在调节蛋白质活性方面发挥重要作用。小泛素样修饰(SUMO化)是一个高度动态的过程,由结合酶和去结合酶活性之间的精确平衡严格调控。它影响蛋白质在细胞内的定位及其与结合伴侣的相互作用,从而改变基因表达。因此,这些变化进而影响调节许多细胞功能的信号传导机制,如细胞生长、增殖、凋亡、DNA修复和细胞存活。越来越明显的是,SUMO途径的失调通过影响许多癌蛋白和肿瘤抑制因子的SUMO化/去SUMO化而导致致癌转化。在包括癌症在内的多种疾病类型的许多研究中都报道了SUMO化和去SUMO化之间的平衡丧失。本章总结了失调的SUMO途径影响癌基因和肿瘤抑制基因的机制和功能。

相似文献

1
Sumoylation and Its Contribution to Cancer.SUMO化修饰及其在癌症中的作用
Adv Exp Med Biol. 2017;963:283-298. doi: 10.1007/978-3-319-50044-7_17.
2
SUMO pathway components as possible cancer biomarkers.小泛素样修饰物(SUMO)途径成分作为潜在的癌症生物标志物。
Future Oncol. 2015;11(11):1599-610. doi: 10.2217/fon.15.41.
3
Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.小泛素样修饰物(SUMO)途径功能丧失对癌细胞和肿瘤增殖的特征分析。
PLoS One. 2015 Apr 10;10(4):e0123882. doi: 10.1371/journal.pone.0123882. eCollection 2015.
4
Roles of Ubiquitination and SUMOylation in DNA Damage Response.泛素化和 SUMO 化在 DNA 损伤反应中的作用。
Curr Issues Mol Biol. 2020;35:59-84. doi: 10.21775/cimb.035.059. Epub 2019 Aug 18.
5
SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.SUMOylation 修饰 ATF3 改变了其对 TP53 基因调控的转录活性。
J Cell Biochem. 2013 Mar;114(3):589-98. doi: 10.1002/jcb.24396.
6
The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.共激活因子 AIB1 的转录活性受 SUMO E3 连接酶 PIAS1 的调节。
Biol Cell. 2012 May;104(5):287-96. doi: 10.1111/boc.201100116. Epub 2012 Mar 7.
7
Dysregulation of ubiquitin ligases in cancer.癌症中泛素连接酶的失调。
Drug Resist Updat. 2015 Nov;23:1-11. doi: 10.1016/j.drup.2015.09.001. Epub 2015 Sep 28.
8
Regulation of the sumoylation system in gene expression.基因表达中SUMO化系统的调控。
Curr Opin Cell Biol. 2008 Jun;20(3):288-93. doi: 10.1016/j.ceb.2008.03.014. Epub 2008 May 28.
9
SUMOylation in carcinogenesis.SUMOylation 在癌症发生中的作用。
Cancer Lett. 2012 Mar 28;316(2):113-25. doi: 10.1016/j.canlet.2011.10.036. Epub 2011 Nov 2.
10
Sumoylation as an Integral Mechanism in Bacterial Infection and Disease Progression.SUMO化作为细菌感染和疾病进展中的一种整体机制
Adv Exp Med Biol. 2017;963:389-408. doi: 10.1007/978-3-319-50044-7_22.

引用本文的文献

1
Metabolic pathways, genomic alterations, and post-translational modifications in pulmonary hypertension and cancer as therapeutic targets and biomarkers.作为治疗靶点和生物标志物的肺动脉高压及癌症中的代谢途径、基因组改变和翻译后修饰。
Front Pharmacol. 2024 Nov 20;15:1490892. doi: 10.3389/fphar.2024.1490892. eCollection 2024.
2
Expression of SUMO and NF-κB genes in hepatitis B virus-associated hepatocellular carcinoma patients: An observational study.乙型肝炎病毒相关性肝细胞癌患者 SUMO 和 NF-κB 基因的表达:一项观察性研究。
Medicine (Baltimore). 2024 Jun 28;103(26):e38737. doi: 10.1097/MD.0000000000038737.
3
ROS-mediated up-regulation of SAE1 by Helicobacter pylori promotes human gastric tumor genesis and progression.
幽门螺杆菌通过 ROS 介导上调 SAE1 促进人胃肿瘤的发生和发展。
J Transl Med. 2024 Feb 13;22(1):148. doi: 10.1186/s12967-024-04913-5.
4
Adenovirus E1B-55K controls SUMO-dependent degradation of antiviral cellular restriction factors.腺病毒 E1B-55K 控制 SUMO 依赖性降解抗病毒细胞限制因子。
J Virol. 2023 Nov 30;97(11):e0079123. doi: 10.1128/jvi.00791-23. Epub 2023 Nov 2.
5
Updates in pathobiological aspects of anaplastic large cell lymphoma.间变性大细胞淋巴瘤病理生物学方面的进展
Front Oncol. 2023 Sep 22;13:1241532. doi: 10.3389/fonc.2023.1241532. eCollection 2023.
6
The role of post-translational modifications in driving abnormal cardiovascular complications at high altitude.翻译后修饰在引发高原异常心血管并发症中的作用
Front Cardiovasc Med. 2022 Sep 14;9:886300. doi: 10.3389/fcvm.2022.886300. eCollection 2022.
7
The UBC9/SUMO pathway affects E-cadherin cleavage in HPV-positive head and neck cancer.UBC9/小泛素样修饰蛋白(SUMO)途径影响人乳头瘤病毒(HPV)阳性头颈癌中E-钙黏蛋白的切割。
Front Mol Biosci. 2022 Aug 12;9:940449. doi: 10.3389/fmolb.2022.940449. eCollection 2022.
8
Post-translational modifications of CDK5 and their biological roles in cancer.细胞周期蛋白依赖性激酶5的翻译后修饰及其在癌症中的生物学作用
Mol Biomed. 2021 Jul 20;2(1):22. doi: 10.1186/s43556-021-00029-0.
9
A somatic UBA2 variant preceded ETV6-RUNX1 in the concordant BCP-ALL of monozygotic twins.同卵双胞胎中一致表达的 BCP-ALL 中,存在 UBA2 种系变异先于 ETV6-RUNX1 的情况。
Blood Adv. 2022 Apr 12;6(7):2275-2289. doi: 10.1182/bloodadvances.2021005703.
10
SUMOylation regulates Rb hyperphosphorylation and inactivation in uveal melanoma.SUMOylation 调控葡萄膜黑素瘤中 Rb 的过度磷酸化和失活。
Cancer Sci. 2022 Feb;113(2):622-633. doi: 10.1111/cas.15223. Epub 2021 Dec 20.